Why do our patients get chemotherapy until the end of life?
Author:
- 13 September 2011
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 22 (11) , 2345-2348
Abstract
Some years ago, I treated a 21-year-old woman. During her first pregnancy, an enlarging mass appeared in her right leg. Diagnostic procedures done after delivery indicated that she had alveolar rhabdomyosarcoma. She was referred to the cancer center for isolated limb perfusion, which was deemed impossible due to inguinal masses encountered during the attempt to canalize the femoral vessels. A computed tomography scan showed peripheral micronodules in both lungs, after which she was referred to the medical oncology department for systemic chemotherapy. By then, the primary tumor was a fungating mass requiring morphine for pain control. Treatment with cyclophosphamide, doxorubicin and vincristine led to a prolonged hospital admission for bacterial sepsis, during which she was visited by her husband daily late after work and on Sundays by her family and the baby. On the subsequent cycle, and despite reduced chemotherapy doses, she again experienced severe hematological toxicity and no antitumor effect or decreased requirement of narcotics. Next, single-agent doxorubicin was administered in the outpatient clinic as an attempt to preserve quality of life. Still no antitumor or symptom response was achieved and multiple hospital admissions due to hematological toxicity ensued. Eventually, ifosfamide was prescribed in progressively lower doses due to increasing hematological toxicity but still without clinical benefit. She finally died of fungal sepsis, 3 months after being referred to the medical oncology department.Keywords
This publication has 29 references indexed in Scilit:
- Palliative chemotherapy during the last month of lifeAnnals of Oncology, 2011
- Chemotherapy use at the End of Life. A Retrospective Single Centre Experience AnalysisTumori Journal, 2011
- Aggressiveness of Cancer-Care near the End-of-Life in KoreaJapanese Journal of Clinical Oncology, 2008
- Use of chemotherapy at the end of life in a Portuguese oncology centerSupportive Care in Cancer, 2007
- The aggressiveness of cancer care in the last three months of life: a retrospective single centre analysisPsycho-Oncology, 2007
- Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patientsBritish Journal of Cancer, 2006
- Why Do Patients Choose Chemotherapy Near the End of Life? A Review of the Perspective of Those Facing Death From CancerJournal of Clinical Oncology, 2006
- Looking Back From Death: The Value of Retrospective Studies of End-of-Life CareJournal of Clinical Oncology, 2006
- Trends in the Aggressiveness of Cancer Care Near the End of LifeJournal of Clinical Oncology, 2004
- Chemotherapy Use among Medicare Beneficiaries at the End of LifeAnnals of Internal Medicine, 2003